Characterization of the Nutritional Status in the Patient With Liver Cirrhosis

Not Applicable

Completed

• Conditions: Sarcopenia

• Registration Number: NCT04073693
• Lead Sponsor: Puerta de Hierro University Hospital

Brief Summary

In the subgroup of patients with sarcopenia, regardless of their body mass index, we want to verify the real impact of nutritional supplements with branched chain amino acids on the standard treatment based on nutritional intervention and physical exercise.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-08-01
• Status Verified: 2019-08
• Primary Completion: 2019-08-01
• Study Completion: 2019-08-09
• Study First Submitted: 2019-08-09
• Study First Submitted QC: 2019-08-27
• Last Update Submitted: 2019-08-27
• Study First Posted: 2019-08-29
• Last Update Posted: 2019-08-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Cirrhotic patients with sarcopenia in abdominal CT.

Exclusion Criteria

• chronic renal failure or being on hemodialysis
• active hepatitis B or C virus infection
• active alcohol abuse
• coinfection with human immunodeficiency virus
• renal or previous liver transplantation
• history of neoplasia requiring chemotherapy or radiotherapy
• hepatocellular carcinoma outside of Milan criteria
• TIPs
• unwillingness to participate in the study.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change of muscle mass in patients with sarcopenia	12 weeks	To assess whether to add to dietary and physical activity recommendations, nutritional supplements with BRCA under usual clinical conditions can lead to a greater change of muscle mass in patients with sarcopenia

Trial Locations

Locations (1)

Jose Luis Calleja; 🇪🇸 Majadahonda, Madrid, Spain